Risk and special populations

Version vom 20. Mai 2020, 22:14 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

identifying factors

• OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients.

32233642 2020. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus
32232218 2020. Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis
32304772 ä. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019�From a Nationwide Analysis in China
32118640 ä. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Frailty
32268300 2020. Biomarkers of biological age as predictors of COVID-19 disease severity
32339960 2020. Clinical characteristics of older patients infected with COVID-19: A descriptive study
32331795 ä. Afectacion clinica y sintomatoligica en pacientes mayores de 65 anos por COVID-19
32269670 2020. Canadian Geriatrics Society COVID-19 Recommendations for Older Adults What Do Older Adults Need To Know?

Comorbidity
32267833 2020. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis

Diabetes, Obesity, low androgens
32249357 ä. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic

• [1]

32345580 2020. Diabetes and covid-19: a global health challenge
32345579 2020. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes

ACEi ARBs
32363137 ä. Anti-RAS drugs and SARS-CoV-2 infection
32370986 ä. Renin-angiotensin-aldosterone system and COVID-19 infection
32286678 2020. Inhibitors of the renin-angiotensin system: The potential role in the pathogenesis of COVID-19

Heart
32331955 ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis
32326691 2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction
32277299 2020. Perspective: cardiovascular disease and the Covid-19 pandemic
32293003 ä. Hypertension, the renin?angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence
32335068 ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock

Kidney, Hemodialysis
32240718 ä. COVID-19 in Hemodialysis Patients: A Report of 5 Cases
32276031 ä. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle

Gynecology, Obstetrics, Pregnancy, Neonate
32105680 ä. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know
32363337 ä. Severe ARDS in COVID-19-infected pregnancy: obstetric and intensive care considerations
32363336 ä. Two cases of coronavirus 2019-related cardiomyopathy in pregnancy
32292903 ä. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals
C7104131 ä. Outcome of Coronavirus spectrum infections (SARS, MERS, COVID 1 -19) during pregnancy: a systematic review and meta-analysis
32333857 ä. Coronavirus disease 2019 in pregnancy: consider thromboembolic disorders and thromboprophylaxis
32311350 ä. COVID19 during pregnancy: a systematic review of reported cases
32335053 ä. Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases
32360108 ä. Maternal Death Due to COVID-19 Disease
32348744 ä. Maternal Deaths with Covid19: a different outcome from mid to low resource countries?
32245738 2020. Primer caso de infeccion neonatal por SARS-CoV-2 en Espana
32363217 ä. First case of neonatal infection due to COVID 19 in Spain?
32341945 ä. COVID-19: Fever syndrome and neurological symptoms in a neonate?

Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak

On immunomodulators: rheumatic, transplant, dermatology, neurology
32264666 2020. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
32363045 ä. Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients

HIV
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

other pharmacology

• ACEI/AT1RA not risky ?
• dextrometorphan (antitussive compd)

Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic

indoor livin ppl

• no sunlight no vitamin d

Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations

32371563 2020. Asthma increases risk of severity of COVID-19
32360479 ä. 2019 novel coronavirus disease (COVID-19) in hemodialysis patients: a report of two cases
32360811 ä. Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts
32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32249918 ä. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study
32215613 ä. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System?a Call for Epidemiologic Investigations
32182347 ä. Perinatal Transmissionof COVID-19 Associated SARS-CoV-2:Should We Worry?
32161941 ä. A case report of neonatal COVID-19 infection in China
32119083 ä. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery
32271368 ä. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission
32270178 ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV
32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?
32339215 ä. Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19
32337584 ä. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit
32297925 ä. Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2
32278081 ä. Association of COVID-19 infection with pregnancy outcomes in healthcare workers and general women

32304745 ä. Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China
32161990 ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
32328736 ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity
32376643 2020. Postpartum exacerbation of antenatal COVID-19 pneumonia in 3 women
32332039 2020. Renin-angiotensin-aldosterone system inhibitors and COVID-19
32357998 2020. Cardiac considerations in patients with COVID-19
32332038 2020. Asthma and COVID-19
32264922 2020. COVID-19 and the RAAS?a potential role for angiotensin II?
32291526 2020. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB
32350632 2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty
32219626 ä. Experience of Clinical Management for Pregnant Women and Newborns with Novel Coronavirus Pneumonia in Tongji Hospital, China

32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times
32247213 2020. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc)
32298981 2020. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32334395 ä. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia ? A systematic review, meta-analysis, and meta-regression?
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32213760 2020. Facts and reflections on COVID-19 and anti-hypertensives drugs
32303915 ä. Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
C7143201 ä. Preventive measures and management of COVID-19 in pregnancy
32323279 2020. Renin-Angiotensin-System (RAS) und COVID-19 - Zur Verordnung von RAS-Blockern
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32256705 2020. Associations between immune-suppressive and stimulating drugs and novel COVID-19?a systematic review of current evidence

32328575 ä. Age, frailty and diabetes ? triple jeopardy for vulnerability to COVID-19 infection
32322805 ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19 in people living with HIV
32372857 2020. COVID-19 pandemic and the risk of infection in multiple sclerosis patients on disease modifying therapies: ?what the bleep do we know??
32250244 2020. Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
32324118 2020. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States